Summarized by Masters of Longevity from Longevity Technology.
A ten‑patient trial began testing a manufactured vascular graft for bypass.

Key Takeaways
- Humacyte started a ten‑patient trial of an off‑the‑shelf graft.
- The graft is intended to replace harvesting a patient’s leg vein.
- Human efficacy and safety remain unproven in this early trial.



